Skip to content
healthcare.dev
Get a free key

Atelvia

NDC 0430-0979, risedronate sodium, tablet, delayed release, from Allergan, Inc..

Product NDC
0430-0979
Status
Listed
Labeler
Allergan, Inc.
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022560
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0430-0979 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RISEDRONATE SODIUM HEMIPENTAHYDRATE30.1 mg/1
  • RISEDRONATE SODIUM MONOHYDRATE4.9 mg/1

Pharmacologic classes

Bisphosphonate [EPC]; Bisphosphonate [EPC]; Diphosphonates [CS]; Diphosphonates [CS]

Package NDCNDC-11Package
0430-0979-03004300979034 TABLET, DELAYED RELEASE in 1 DOSE PACK (0430-0979-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c8b9ab88-1a26-46c3-80ec-4eaa45202021

  • NADAC price for package 00430097903

    GET /v1/drugs/nadac/00430097903

Use it

Look up 0430-0979 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0430-0979 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0430-0979. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.